Sanofi P/E Ratio
Sanofi P/E ratio. Sanofi (SANOFI) P/E ratio is 20.14 (Moderate), EPS (TTM) ₹179.46, current price ₹3024.20 on NSE vs historical average P/E of 30.32 (50.0th percentile) — High - Growth expectations or overvalued. Also explore SANOFI share price data to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SANOFI P/E Ratio — Valuation Signal & Historical Context
Sanofi P/E 20.14 vs historical average 30.32, range 20.0–40.64 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see SANOFI screener.
- Current PE is 33.6% below historical average
- Trading at discount to sector average PE of 56.48
Sanofi P/E Ratio Historical Trend
SANOFI annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 20.14 vs historical average 30.32. Examine SANOFI earnings for recent quarterly revenue, profit and EPS trends.
SANOFI Historical P/E Ratio — EPS, Year-End Price & Valuation
Sanofi annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 40.64 | 179.45 | ₹7292.15 | NSE | High |
| 2023 | 20.0 | 261.89 | ₹5238.10 | NSE | Moderate |
SANOFI vs Healthcare Peers — P/E Ratio Comparison
Sanofi P/E 20.14 vs Healthcare average 56.48, median 32.41 — range 2.04–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |